HB
Heather J Bax
King's College London
Research areas: Immunology and Microbiology · Immunology · Monoclonal and Polyclonal Antibodies Research · Cancer Immunotherapy and Biomarkers · HER2/EGFR in Cancer Research
0000-0003-0432-4160
Employment
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (74)
- Nonallergic urticarial skin reactions associated with MOv18 IgE, a first-in-class IgE antibody recognizing folate receptor alpha (FRα): linking allergooncology with dermatology Save
- Assessment of biophysical properties of the first-in-class anti-cancer IgE antibody drug MOv18 IgE demonstrates monomeric purity and stability Save
- Physiochemical and functional evaluation of the first-in-class anti-cancer IgE antibody drug, MOv18, through process development and good manufacturing practice production Save
- Hyperinflammatory repolarisation of ovarian cancer patient macrophages by anti-tumour IgE antibody, MOv18, restricts an immunosuppressive macrophage:Treg cell interaction Save
- Allergooncology: Application of the basophil activation test (BAT) in pre-clinical testing and the first-in-class clinical trial of anticancer IgE immunotherapy Save
- Allergooncology: Non-allergic urticarial skin reactions associated with MOv18 IgE, a first-in-class IgE antibody recognizing folate receptor alpha (FRα) Save
- Allergooncology: Novel crusade for basophil activation test Save
- An IgE antibody targeting HER2 identified by clonal selection restricts breast cancer growth via immune-stimulating activities Save
- Basophil Activation Test: Bridging Allergy and Oncology for Diagnostic, Therapeutic and Prognostic Applications in AllergoOncology: An EAACI Position Paper Save
- EPS 226, a novel HER2 targeting IgE therapeutic, delivers immune dependent anti-tumor activity in preclinical models of breast cancer Save
- Fc-mediated immune stimulating, pro-inflammatory and antitumor effects of anti-HER2 IgE against HER2-expressing and trastuzumab-resistant tumors Save
- Hybrid IgE-IgG1 antibodies (IgEG): a new antibody class that combines IgE and IgG functionality Save
- Molecular Signatures and Functional Pathways of Human Monocytes and Macrophages in Allergy: An EAACI AllergoOncology Scoping Review Save
- Non-Allergic Urticarial Skin Reactions Associated With MOv18 IgE, a First-In-Class IgE Antibody Recognising Folate Receptor Alpha Save
- Chondroitin Sulfate Proteoglycan 4 (CSPG4) as an Emerging Target for Immunotherapy to Treat Melanoma Save
- Granulocytes and mast cells in AllergoOncology—Bridging allergy to cancer: An EAACI position paper Save
- AllergoOncology: Biomarkers and refined classification for research in the allergy and glioma nexus-A joint EAACI-EANO position paper Save
- Protective effects of allergic diseases in COVID-19 outcomes: A retrospective cohort study in UK Biobank in the general population and in patients with cancer Save
- AllergoOncology: Biomarkers and Refined Classification for Research in the Allergy and Glioma Nexus - a Joint EAACI-EANO Position Paper Save
- A trastuzumab- like monoclonal antibody engineered with IgE Fc regions can exert potent anti-tumour functions Save